Midodrine Viatris (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Viatris, is an Alpha-1 adrenergic agonist presented as an oral tablet for systemic administration. It is used to increase vascular tone and raise blood pressure in patients with orthostatic hypotension, thereby reducing symptoms such as dizziness, light‑headedness, and syncope when standing.

GNH USA supplies Midodrine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across the EU and other global markets. The company adheres to stringent quality standards and provides regulatory support for importers.

Midodrine acts on the autonomic regulation of blood pressure and is indicated for conditions characterized by a drop in standing blood pressure. - Orthostatic hypotension: improves standing blood pressure and reduces dizziness and fainting episodes. - Neurogenic orthostatic hypotension: enhances vascular resistance in patients with autonomic failure. - Post‑ural hypotension: helps maintain adequate cerebral perfusion after sitting or lying down.

Midodrine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Piloerection: localized goose‑flesh skin reaction. - Pruritus: itching without rash. - Urinary urgency: increased frequency of urination. - Supine hypertension: elevated blood pressure while lying down. - Nausea: mild gastrointestinal discomfort. - Headache: transient cranial pain.

Serious or Rare Side Effects: - Severe hypertension: markedly high blood pressure requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm. - Ischemic events: reduced blood flow to extremities. - Allergic reaction: rash, swelling, or anaphylaxis. - Renal impairment: worsening kidney function in susceptible individuals.

Before prescribing Midodrine, clinicians should consider several safety factors. - Blood pressure monitoring: check supine and standing pressures to avoid excessive hypertension. - Cardiovascular disease: use cautiously in patients with coronary artery disease. - Renal function: adjust use in severe renal impairment. - Concomitant vasoconstrictors: avoid additive hypertensive effects. - Pregnancy and lactation: assess risk‑benefit as safety data are limited. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Midodrine can interact with other agents that affect blood pressure or vascular tone.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of hypertensive crisis. - Direct vasoconstrictors (e.g., phenylephrine): additive increase in blood pressure. - Sympathomimetic agents: may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: may blunt the antihypotensive effect. - Antihypertensive drugs: require careful blood pressure monitoring. - Anticholinergic agents: may exacerbate urinary retention. - Tricyclic antidepressants: potential for increased vascular resistance.